VOR

Healthcare Biotechnology

Vor Biopharma Inc.

$18.69

+0.68 +3.78% today

Price History

Not enough data

Key Stats

Market Cap

1.11B

Avg Volume

1.05M

P/E (TTM)

0.10

EPS

$180.18

52W High

$38.31

52W Low

$6.50

Div. Yield

0.0%

Analyst Ratings

Buy

Str Buy

Buy

Hold

Sell

Str Sell

Valuation

Forward P/E

-4.90

P/B Ratio

-5.08

EV/EBITDA

-5.48

Margins

Gross Margin 0.0%

Operating Margin 0.0%

Net Margin 0.0%

EBITDA Margin 0.0%

Growth & Returns

Return on Assets

(21.4%)

Liquidity & Leverage

Current Ratio

19.15

Quick Ratio

18.79

Total Cash

466.13M

Total Debt

2.88M

About

Vor Biopharma Inc., a clinical-stage biopharmaceutical company, focuses on the development of a novel therapy in the treatment of autoimmune diseases. The company offers telitacicept, a novel fusion protein for the treatment of generalized myasthenia gravis, systemic lupus erythematosus, and rheumatoid arthritis, as well as Sjögren's disease and IgA nephrapathy. It has a license agreement with RemeGen Co., Ltd. for the exploitation, development, and commercialization of telitacicpet and related products. The company was incorporated in 2015 and is headquartered in Boston, Massachusetts.